Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy.

Vukovic S, McAdam L, Zlotnik-Shaul R, Amin R.

J Paediatr Child Health. 2018 Sep 23. doi: 10.1111/jpc.14226. [Epub ahead of print] Review.

PMID:
30246272
2.

Development and content validation of the Muscular Dystrophy Child Health Index of Life with Disabilities questionnaire for children with Duchenne muscular dystrophy.

Propp R, McAdam L, Davis AM, Salbach NM, Weir S, Encisa C, Narayanan UG.

Dev Med Child Neurol. 2018 Jul 29. doi: 10.1111/dmcn.13977. [Epub ahead of print]

PMID:
30058069
3.

Enhancing the human dimensions of children's neuromuscular care: piloting a methodology for fostering team reflexivity.

Thille P, Gibson BE, Abrams T, McAdam LC, Mistry B, Setchell J.

Adv Health Sci Educ Theory Pract. 2018 May 24. doi: 10.1007/s10459-018-9834-1. [Epub ahead of print]

PMID:
29797172
4.

The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities.

Wei Y, McCormick A, MacKenzie A, O'Ferrall E, Venance S, Mah JK, Selby K, McMillan HJ, Smith G, Oskoui M, Hogan G, McAdam L, Mabaya G, Hodgkinson V, Lounsberry J, Korngut L, Campbell C.

Paediatr Child Health. 2018 Feb;23(1):20-26. doi: 10.1093/pch/pxx125. Epub 2017 Dec 8.

PMID:
29479275
5.

Enhancing human aspects of care with young people with muscular dystrophy: Results from a participatory qualitative study with clinicians.

Setchell J, Thille P, Abrams T, McAdam LC, Mistry B, Gibson BE.

Child Care Health Dev. 2018 Mar;44(2):269-277. doi: 10.1111/cch.12526. Epub 2017 Nov 8.

PMID:
29119577
6.

Development of a New Self-Reporting Instrument Measuring Benefits and Side Effects of Corticosteroids in Duchenne Muscular Dystrophy: Report from a Pilot Study.

Hendriksen RGF, Lionarons JM, Hendriksen JGM, Vles JSH, McAdam LC, Biggar WD.

J Neuromuscul Dis. 2017;4(3):217-236. doi: 10.3233/JND-170223.

PMID:
28800336
7.

A feasibility study using solution-focused coaching for health promotion in children and young people with Duchenne muscular dystrophy.

McPherson AC, McAdam L, Keenan S, Schwellnus H, Biddiss E, DeFinney A, English K.

Dev Neurorehabil. 2018 Feb;21(2):121-130. doi: 10.1080/17518423.2017.1289271. Epub 2017 Mar 8.

PMID:
28272972
8.

Enablers and barriers of men with Duchenne muscular dystrophy transitioning from an adult clinic within a pediatric hospital.

Lindsay S, McAdam L, Mahendiran T.

Disabil Health J. 2017 Jan;10(1):73-79. doi: 10.1016/j.dhjo.2016.10.002. Epub 2016 Oct 11.

PMID:
27769758
9.

A Novel Mutation in DMD (c.10797+5G>A) Causes Becker Muscular Dystrophy Associated with Intellectual Disability.

Banihani R, Baskin B, Halliday W, Kobayashi J, Kawamura A, McAdam L, Ray PN, Yoon G.

J Dev Behav Pediatr. 2016 Apr;37(3):239-44. doi: 10.1097/DBP.0000000000000262.

PMID:
26836830
10.

Fit for purpose--and for my revalidation requirements.

McAdam L.

Nurs Stand. 2015 Nov 11;30(11):31. doi: 10.7748/ns.30.11.31.s40. No abstract available.

PMID:
26554993
11.

Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy.

Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, McAdam L.

J Child Neurol. 2015 Oct;30(11):1472-82. doi: 10.1177/0883073815570154. Epub 2015 Feb 6.

PMID:
25660133
12.

The CNDR: collaborating to translate new therapies for Canadians.

Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network.

Can J Neurol Sci. 2013 Sep;40(5):698-704.

PMID:
23968944
13.

Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up.

Lebel DE, Corston JA, McAdam LC, Biggar WD, Alman BA.

J Bone Joint Surg Am. 2013 Jun 19;95(12):1057-61. doi: 10.2106/JBJS.L.01577.

PMID:
23783200
14.

Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophy.

McAdam LC, Rastogi A, Macleod K, Douglas Biggar W.

Neuromuscul Disord. 2012 Dec;22(12):1035-9. doi: 10.1016/j.nmd.2012.07.010. Epub 2012 Aug 21.

PMID:
22920089
15.

Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy.

Mayo AL, Craven BC, McAdam LC, Biggar WD.

Neuromuscul Disord. 2012 Dec;22(12):1040-5. doi: 10.1016/j.nmd.2012.06.354. Epub 2012 Jul 21.

PMID:
22824639
16.

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy.

McAdam LC, Mayo AL, Alman BA, Biggar WD.

Acta Myol. 2012 May;31(1):16-20.

17.

Symptomatic dystrophinopathies in female children.

Seemann N, Selby K, McAdam L, Biggar D, Kolski H, Goobie S, Yoon G, Campbell C; Canadian Pediatric Neuromuscular Group.

Neuromuscul Disord. 2011 Mar;21(3):172-7. doi: 10.1016/j.nmd.2010.11.001. Epub 2010 Dec 24.

PMID:
21186124
18.

Pediatric tumefactive demyelination: case series and review of the literature.

McAdam LC, Blaser SI, Banwell BL.

Pediatr Neurol. 2002 Jan;26(1):18-25. Review.

PMID:
11814730
19.

General anaesthetics and their effects on GABA(A) receptor desensitization.

Orser BA, McAdam LC, Roder S, MacDonald JF.

Toxicol Lett. 1998 Nov 23;100-101:217-24. Review.

PMID:
10049145
20.
21.
22.

Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.

Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B.

Cell Growth Differ. 1996 Feb;7(2):263-70.

23.

Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy.

Casciato DA, McAdam LP, Kopple JD, Bluestone R, Goldberg LS, Clements PJ, Knutson DW.

Nephron. 1984;38(1):9-16.

PMID:
6472538
24.

Scleromyxedema myopathy. Histochemical and electron microscopic observations.

Verity MA, Toop J, McAdam LP, Pearson CM.

Am J Clin Pathol. 1978 Apr;69(4):446-51.

PMID:
645644
25.

Papular mucinosis with myopathy, arthritis, and eosinophilia. A histopathologic study.

McAdam LP, Pearson CM, Pitts WH, Sadoff L, Verity MA.

Arthritis Rheum. 1977 May;20(4):989-96.

PMID:
405019
26.

Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans.

Metzger WH, McAdam L, Bluestone R, Guth PH.

Am J Dig Dis. 1976 Nov;21(11):963-8.

PMID:
790946
27.

Clinical and radiological survey of the incidence of osteoarthrosis among obese patients.

Goldin RH, McAdam L, Louie JS, Gold R, Bluestone R.

Ann Rheum Dis. 1976 Aug;35(4):349-53.

28.

Relapsing polychondritis: prospective study of 23 patients and a review of the literature.

McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM.

Medicine (Baltimore). 1976 May;55(3):193-215. Review.

PMID:
775252
29.

The arthropathy of relapsing polychrondritis.

O'Hanlan M, McAdam LP, Bluestone R, Pearson CM.

Arthritis Rheum. 1976 Mar-Apr;19(2):191-4.

PMID:
1259793
30.

Adenocarcinoma of the lung during azathioprine therapy.

McAdam L, Paulus HE, Peter JB.

Arthritis Rheum. 1974 Jan-Feb;17(1):92-4. No abstract available.

PMID:
4810666

Supplemental Content

Loading ...
Support Center